טוען...
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides
Nonabsorbable disaccharides have been the mainstay of treatment for hepatic encephalopathy since introduced into clinical practice in 1966. Their beneficial effects reflect their ability to reduce the intestinal production/absorption of ammonia. A recent Cochrane review confirmed the efficacy and sa...
שמור ב:
| הוצא לאור ב: | Metab Brain Dis |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5145904/ https://ncbi.nlm.nih.gov/pubmed/27638474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9910-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|